Annual Working Capital
$1.93 B
-$12.59 M-0.65%
31 December 2023
Summary:
Sarepta Therapeutics annual working capital is currently $1.93 billion, with the most recent change of -$12.59 million (-0.65%) on 31 December 2023. During the last 3 years, it has fallen by -$143.50 million (-6.94%). SRPT annual working capital is now -10.49% below its all-time high of $2.15 billion, reached on 31 December 2021.SRPT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$1.99 B
-$9.27 M-0.46%
30 September 2024
Summary:
Sarepta Therapeutics quarterly working capital is currently $1.99 billion, with the most recent change of -$9.27 million (-0.46%) on 30 September 2024. Over the past year, it has dropped by -$14.23 million (-0.71%). SRPT quarterly working capital is now -11.38% below its all-time high of $2.24 billion, reached on 31 March 2020.SRPT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | -0.7% |
| 3 y3 years | -6.9% | +9.6% |
| 5 y5 years | +53.8% | +73.2% |
SRPT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -10.5% | at low | -7.7% | +9.6% |
| 5 y | 5 years | -10.5% | +59.9% | -11.4% | +73.2% |
| alltime | all time | -10.5% | >+9999.0% | -11.4% | >+9999.0% |
Sarepta Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.99 B(-0.5%) |
| June 2024 | - | $2.00 B(+7.5%) |
| Mar 2024 | - | $1.86 B(-3.6%) |
| Dec 2023 | $1.93 B(-0.6%) | $1.93 B(-3.7%) |
| Sept 2023 | - | $2.00 B(+1.3%) |
| June 2023 | - | $1.97 B(+1.2%) |
| Mar 2023 | - | $1.95 B(+0.7%) |
| Dec 2022 | $1.94 B(-9.9%) | $1.94 B(-4.2%) |
| Sept 2022 | - | $2.02 B(+5.2%) |
| June 2022 | - | $1.92 B(-7.3%) |
| Mar 2022 | - | $2.08 B(-3.5%) |
| Dec 2021 | $2.15 B(+4.0%) | $2.15 B(+18.7%) |
| Sept 2021 | - | $1.81 B(-1.5%) |
| June 2021 | - | $1.84 B(-3.5%) |
| Mar 2021 | - | $1.91 B(-7.9%) |
| Dec 2020 | $2.07 B(+71.8%) | $2.07 B(+6.4%) |
| Sept 2020 | - | $1.94 B(-7.6%) |
| June 2020 | - | $2.10 B(-6.1%) |
| Mar 2020 | - | $2.24 B(+86.1%) |
| Dec 2019 | $1.20 B(-3.9%) | $1.20 B(+5.0%) |
| Sept 2019 | - | $1.15 B(-9.4%) |
| June 2019 | - | $1.27 B(-17.5%) |
| Mar 2019 | - | $1.53 B(+22.5%) |
| Dec 2018 | $1.25 B(+9.8%) | $1.25 B(+39.5%) |
| Sept 2018 | - | $897.68 M(-13.2%) |
| June 2018 | - | $1.03 B(-8.3%) |
| Mar 2018 | - | $1.13 B(-1.1%) |
| Dec 2017 | $1.14 B(+282.6%) | $1.14 B(+71.4%) |
| Sept 2017 | - | $665.14 M(+104.9%) |
| June 2017 | - | $324.63 M(-15.2%) |
| Mar 2017 | - | $382.68 M(+28.4%) |
| Dec 2016 | $298.05 M(+83.7%) | $298.05 M(-19.4%) |
| Sept 2016 | - | $369.81 M(+328.7%) |
| June 2016 | - | $86.26 M(-18.3%) |
| Mar 2016 | - | $105.57 M(-34.9%) |
| Dec 2015 | $162.25 M(-23.1%) | $162.25 M(+92.1%) |
| Sept 2015 | - | $84.44 M(-41.1%) |
| June 2015 | - | $143.43 M(-9.9%) |
| Mar 2015 | - | $159.14 M(-24.6%) |
| Dec 2014 | $210.93 M(-10.2%) | $210.93 M(-14.6%) |
| Sept 2014 | - | $247.09 M(-10.2%) |
| June 2014 | - | $275.27 M(+30.1%) |
| Mar 2014 | - | $211.61 M(-9.9%) |
| Dec 2013 | $234.84 M(+104.2%) | $234.84 M(-1.9%) |
| Sept 2013 | - | $239.32 M(+197.4%) |
| June 2013 | - | $80.47 M(+10.3%) |
| Mar 2013 | - | $72.94 M(-36.6%) |
| Dec 2012 | $115.02 M(+367.9%) | $115.02 M(-982.0%) |
| Sept 2012 | - | -$13.04 M(-181.0%) |
| June 2012 | - | $16.10 M(+108.9%) |
| Mar 2012 | - | $7.71 M(-68.6%) |
| Dec 2011 | $24.58 M(-406.6%) | $24.58 M(-3.3%) |
| Sept 2011 | - | $25.41 M(-12.6%) |
| June 2011 | - | $29.09 M(-715.6%) |
| Mar 2011 | - | -$4.72 M(-41.1%) |
| Dec 2010 | -$8.02 M | -$8.02 M(+452.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | -$1.45 M(-154.5%) |
| June 2010 | - | $2.66 M(-85.0%) |
| Mar 2010 | - | $17.81 M(+0.0%) |
| Dec 2009 | $17.80 M(+82.5%) | $17.80 M(+28.2%) |
| Sept 2009 | - | $13.89 M(-808.9%) |
| June 2009 | - | -$1.96 M(-111.4%) |
| Mar 2009 | - | $17.16 M(+75.9%) |
| Dec 2008 | $9.76 M(-48.5%) | $9.76 M(+8.5%) |
| Sept 2008 | - | $8.99 M(-34.4%) |
| June 2008 | - | $13.72 M(+3.8%) |
| Mar 2008 | - | $13.22 M(-30.3%) |
| Dec 2007 | $18.96 M(-38.4%) | $18.96 M(+163.2%) |
| Sept 2007 | - | $7.20 M(-55.9%) |
| June 2007 | - | $16.33 M(-31.9%) |
| Mar 2007 | - | $23.96 M(-22.2%) |
| Dec 2006 | $30.79 M(-32.9%) | $30.79 M(-17.0%) |
| Sept 2006 | - | $37.11 M(-13.4%) |
| June 2006 | - | $42.84 M(-11.8%) |
| Mar 2006 | - | $48.56 M(+5.8%) |
| Dec 2005 | $45.91 M(+155.8%) | $45.91 M(+58.4%) |
| Sept 2005 | - | $28.98 M(-5.0%) |
| June 2005 | - | $30.50 M(-13.3%) |
| Mar 2005 | - | $35.20 M(+96.1%) |
| Dec 2004 | $17.95 M(-48.2%) | $17.95 M(-20.1%) |
| Sept 2004 | - | $22.45 M(-18.3%) |
| June 2004 | - | $27.48 M(-20.1%) |
| Mar 2004 | - | $34.41 M(-0.7%) |
| Dec 2003 | $34.64 M(+126.7%) | $34.64 M(+33.2%) |
| Sept 2003 | - | $26.01 M(-11.8%) |
| June 2003 | - | $29.48 M(+169.0%) |
| Mar 2003 | - | $10.96 M(-28.3%) |
| Dec 2002 | $15.28 M(-36.9%) | $15.28 M(-15.6%) |
| Sept 2002 | - | $18.11 M(-31.2%) |
| June 2002 | - | $26.31 M(-21.2%) |
| Mar 2002 | - | $33.38 M(+37.8%) |
| Dec 2001 | $24.23 M(-22.9%) | $24.23 M(-11.0%) |
| Sept 2001 | - | $27.24 M(-20.5%) |
| June 2001 | - | $34.25 M(+32.4%) |
| Mar 2001 | - | $25.86 M(-17.7%) |
| Dec 2000 | $31.41 M(+193.5%) | $31.41 M(-15.0%) |
| Sept 2000 | - | $36.95 M(+289.3%) |
| June 2000 | - | $9.49 M(-30.5%) |
| Mar 2000 | - | $13.66 M(+27.7%) |
| Dec 1999 | $10.70 M(+37.2%) | $10.70 M(+529.4%) |
| Sept 1999 | - | $1.70 M(-57.5%) |
| June 1999 | - | $4.00 M(-33.3%) |
| Mar 1999 | - | $6.00 M(-23.1%) |
| Dec 1998 | $7.80 M(-54.7%) | $7.80 M(-24.3%) |
| Sept 1998 | - | $10.30 M(-27.0%) |
| June 1998 | - | $14.10 M(-10.8%) |
| Mar 1998 | - | $15.80 M(-8.1%) |
| Dec 1997 | $17.20 M(+537.0%) | $17.20 M(-2.8%) |
| Sept 1997 | - | $17.70 M(+6.0%) |
| June 1997 | - | $16.70 M(+778.9%) |
| Mar 1997 | - | $1.90 M |
| Dec 1996 | $2.70 M | - |
FAQ
- What is Sarepta Therapeutics annual working capital?
- What is the all time high annual working capital for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual working capital year-on-year change?
- What is Sarepta Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly working capital year-on-year change?
What is Sarepta Therapeutics annual working capital?
The current annual working capital of SRPT is $1.93 B
What is the all time high annual working capital for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual working capital is $2.15 B
What is Sarepta Therapeutics annual working capital year-on-year change?
Over the past year, SRPT annual working capital has changed by -$12.59 M (-0.65%)
What is Sarepta Therapeutics quarterly working capital?
The current quarterly working capital of SRPT is $1.99 B
What is the all time high quarterly working capital for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly working capital is $2.24 B
What is Sarepta Therapeutics quarterly working capital year-on-year change?
Over the past year, SRPT quarterly working capital has changed by -$14.23 M (-0.71%)